| 1 |
35259564 | Contribution of cyclooxygenase-1-dependent prostacyclin synthesis to bradykinin-induced dermal extravasation. | 2022 Apr |
1 |
| 2 |
29775649 | Expression and function of TLR4- induced B1R bradykinin receptor on cardiac fibroblasts. | 2018 Jul 15 |
1 |
| 3 |
26660642 | Time-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin). | 2016 Mar |
1 |
| 4 |
27069632 | Comparative effects of immediate-release and extended-release aspirin on basal and bradykinin-stimulated excretion of thromboxane and prostacyclin metabolites. | 2016 Apr |
2 |
| 5 |
24584737 | Acute intravenous injection of serelaxin (recombinant human relaxin-2) causes rapid and sustained bradykinin-mediated vasorelaxation. | 2014 Feb 28 |
2 |
| 6 |
23883876 | Linoleic acid attenuates endothelium-derived relaxing factor production by suppressing cAMP-hydrolyzing phosphodiesterase activity. | 2013 |
2 |
| 7 |
22301626 | Role of cyclooxygenase-1-mediated prostacyclin synthesis in endothelium-dependent vasoconstrictor activity of porcine interlobular renal arteries. | 2012 May 1 |
2 |
| 8 |
20082561 | Evidence for prostacyclin and cAMP upregulation by bradykinin and insulin-like growth factor 1 in vascular smooth muscle cells. | 2010 Apr |
3 |
| 9 |
19442326 | Hypertension and the bradykinin system. | 2009 Jun |
1 |
| 10 |
18037911 | Differential effects of glucose on agonist-induced relaxations in human mesenteric and subcutaneous arteries. | 2008 Feb |
1 |
| 11 |
18083112 | Identification of lipopolysaccharide binding site on high molecular weight kininogen. | 2008 Feb 22 |
2 |
| 12 |
18156442 | IL-1beta, BK, and TGF-beta1 attenuate PGI2-mediated cAMP formation in human pulmonary artery smooth muscle cells by multiple mechanisms involving p38 MAP kinase and PKA. | 2008 Mar |
5 |
| 13 |
17666198 | New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. | 2007 Aug 6 |
1 |
| 14 |
16242459 | Hypoxia-reoxygenation, St. Thomas cardioplegic solution, and nicorandil on endothelium-derived hyperpolarizing factor in coronary microarteries. | 2005 Nov |
1 |
| 15 |
20527397 | [The influence of tissue and plasma angiotensin converting enzyme inhibitors on haemostasis with respect to experimental and clinical investigations]. | 2005 Oct |
1 |
| 16 |
14670842 | Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregulation of adenylyl cyclase isoforms 1, 2, and 4. | 2004 Feb 20 |
3 |
| 17 |
15023566 | Nitric oxide: inhibitory effects on endothelial cell calcium signaling, prostaglandin I2 production and nitric oxide synthase expression. | 2004 Apr 1 |
1 |
| 18 |
12573493 | Cytochrome P450 epoxygenases and vascular tone: novel role for HMG-CoA reductase inhibitors in the regulation of CYP 2C expression. | 2003 Feb 17 |
1 |
| 19 |
12826020 | Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole. | 2003 Oct |
1 |
| 20 |
12870664 | Effects of cytochrome P450 inhibitors on agonist-induced Ca2+ responses and production of NO and PGI2 in vascular endothelial cells. | 2003 Jun |
1 |
| 21 |
12133028 | Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure? | 2002 Jul |
2 |
| 22 |
12152253 | [The effect of acetylsalicylic acid on hypotensive action of enalapril in hypertensive patients]. | 2002 |
1 |
| 23 |
12381678 | The Na-K-ATPase is a target for an EDHF displaying characteristics similar to potassium ions in the porcine renal interlobar artery. | 2002 Nov |
1 |
| 24 |
12433966 | Reduced function of endothelial prostacyclin in human omental resistance arteries in pre-eclampsia. | 2002 Nov 15 |
1 |
| 25 |
11208485 | Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation. | 2001 Jan-Feb |
4 |
| 26 |
11392475 | Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events. | 2001 Apr |
1 |
| 27 |
10826452 | Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure? | 2000 May 22 |
1 |
| 28 |
10948078 | Effects of bradykinin on prostaglandin I(2) synthesis in human vascular endothelial cells. | 2000 Aug |
5 |
| 29 |
11056091 | Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway. | 2000 Oct 31 |
1 |
| 30 |
9933251 | Glucocorticoids downregulate cyclooxygenase-1 gene expression and prostacyclin synthesis in fetal pulmonary artery endothelium. | 1999 Feb 5 |
1 |
| 31 |
10216428 | [Approach to bronchial hyperreactivity in vitro]. | 1999 Jan-Feb |
1 |
| 32 |
10384200 | Altered endothelium-derived hyperpolarizing factor-mediated endothelial function in coronary microarteries by St Thomas' Hospital solution. | 1999 Jul |
1 |
| 33 |
10415540 | Interaction of bradykinin with angiotensin, prostacyclin, and nitric oxide in myocardial preservation. | 1999 Jun 30 |
1 |
| 34 |
10458930 | A role of protein kinase C in the regulation of cytosolic phospholipase A(2) in bradykinin-induced PGI(2) synthesis by human vascular endothelial cells. | 1999 Sep |
9 |
| 35 |
10535387 | Plasma levels of nitric oxide and related vasoactive factors following long-term treatment with angiotensin-converting enzyme inhibitor in patients with essential hypertension. | 1999 Oct |
1 |
| 36 |
10803488 | Prostacyclin: its pathogenic role in essential hypertension and the class effect of ACE inhibitors on prostaglandin metabolism. | 1999 |
1 |
| 37 |
9597423 | The endothelium in acute coronary syndromes. | 1998 Apr |
1 |
| 38 |
9605596 | Combination of ACE inhibitors and calcium antagonists: a logical approach. | 1998 |
1 |
| 39 |
9635158 | Effect of endothelium removal on prostaglandin and nitric oxide function in pulmonary resistance arteries in the lamb. | 1998 Feb |
1 |
| 40 |
9649571 | Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium. | 1998 Jul 1 |
1 |
| 41 |
9717056 | Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure. | 1998 Jul |
1 |
| 42 |
9781934 | Endothelium-derived hyperpolarizing factor activates Ca2+-activated K+ channels in porcine coronary artery smooth muscle cells. | 1998 Oct |
1 |
| 43 |
9860207 | Endothelial prostacyclin (PGI-2) production of human and porcine valve allografts related to ischemic history. | 1998 Nov |
1 |
| 44 |
9876291 | Role of non-nitric oxide non-prostaglandin endothelium-derived relaxing factor(s) in bradykinin vasodilation. | 1998 Sep |
3 |
| 45 |
9877481 | In vitro-induced human airway hyperresponsiveness to bradykinin. | 1998 Dec |
1 |
| 46 |
17013240 | Inhibitors of the renin angiotensin system: implications for the anaesthesiologist. | 1998 Jun |
1 |
| 47 |
9429844 | Endothelial function and bradykinin in humans. | 1997 |
1 |
| 48 |
8856131 | A preliminary study of prostaglandin release by bradykinin (BK) on isolated human myometrium. | 1996 Jun |
5 |
| 49 |
8930174 | Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin. | 1996 Nov |
4 |
| 50 |
8971427 | Effect of captopril on prostacyclin and nitric oxide formation in healthy human subjects: interaction with low dose acetylsalicylic acid. | 1996 Dec |
1 |